Literature DB >> 2971639

Increased intratumor concentration of fluorescein-isothiocyanate-labeled neocarzinostatin in rats under angiotensin-induced hypertension.

I Abe1, K Hori, S Saito, S Tanda, Y L Li, M Suzuki.   

Abstract

On the basis of the observation that the tumor tissue blood flow selectively increases under angiotensin (AT)-induced hypertension, the change of the drug concentration in the tumor and normal tissues was examined in male Donryu rats. The intratumor concentration of fluorescein isothiocyanate-labeled neocarzinostatin was about 2-fold higher in the AT-induced hypertension group than in the control up to 20 min after the drug injection. In the normal organs or the uninvolved organs of the tumor-bearing rats, however, no clear increase was seen in the experimental group compared with the control, as anticipated from the observation of the tissue blood flow. The present study supports the hypothesis that the enhanced anticancer effect in chemotherapy under AT-induced hypertension formerly reported is due to the tumor-selective enhancement of the drug delivery.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2971639      PMCID: PMC5917601          DOI: 10.1111/j.1349-7006.1988.tb00050.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  13 in total

1.  Relationship between size and perfusion rate of transplanted tumors.

Authors:  S CATALAND; C COHEN; L A SAPIRSTEIN
Journal:  J Natl Cancer Inst       Date:  1962-08       Impact factor: 13.506

2.  Fate and distribution of [14C] succinyl neocarzinostatin in rats.

Authors:  H Maeda; N Yamamoto; A Yamashita
Journal:  Eur J Cancer       Date:  1976-11       Impact factor: 9.162

3.  [Study on the localization of neocarzinostatin in various tissues by enzyme-labeled antibody method--with special reference to the distribution into oral region (author's transl)].

Authors:  T Shimada
Journal:  Kokubyo Gakkai Zasshi       Date:  1981-03

4.  [Clinical studies on induced hypertension chemotherapy based on functional characteristics of microcirculation of tumor vessels].

Authors:  A Wakui; H Sato
Journal:  Gan To Kagaku Ryoho       Date:  1984-03

5.  Changes in drug delivery (by blood-brain barrier dysfunction) on arachnoid leukemia: implication for CNS leukemic dissemination.

Authors:  M Suzuki; I Abe; H Sato
Journal:  Clin Exp Metastasis       Date:  1983 Apr-Jun       Impact factor: 5.150

6.  Increase in tumor vascular area due to increased blood flow by angiotensin II in rats.

Authors:  K Hori; M Suzuki; I Abe; S Saito; H Sato
Journal:  J Natl Cancer Inst       Date:  1985-02       Impact factor: 13.506

7.  Functional characterization of the microcirculation in tumors.

Authors:  M Suzuki; K Hori; I Abe; S Saito; H Sato
Journal:  Cancer Metastasis Rev       Date:  1984       Impact factor: 9.264

8.  Studies on the exchange of fluids between host and tumor. II. The blood flow of hepatomas and other tumors in rats and mice.

Authors:  P M GULLINO; F H GRANTHAM
Journal:  J Natl Cancer Inst       Date:  1961-12       Impact factor: 13.506

9.  A new approach to cancer chemotherapy: selective enhancement of tumor blood flow with angiotensin II.

Authors:  M Suzuki; K Hori; I Abe; S Saito; H Sato
Journal:  J Natl Cancer Inst       Date:  1981-09       Impact factor: 13.506

Review 10.  Some aspects of size-dependent differential drug response in primary and metastatic tumors.

Authors:  I Abe; M Suzuki; K Hori; S Saito; H Sato
Journal:  Cancer Metastasis Rev       Date:  1985       Impact factor: 9.264

View more
  8 in total

Review 1.  Improving delivery and efficacy of nanomedicines in solid tumors: role of tumor priming.

Authors:  Jie Wang; Ze Lu; Yue Gao; M Guillaume Wientjes; Jessie L-S Au
Journal:  Nanomedicine (Lond)       Date:  2011-11       Impact factor: 5.307

Review 2.  Delivery of cancer therapeutics to extracellular and intracellular targets: Determinants, barriers, challenges and opportunities.

Authors:  Jessie L-S Au; Bertrand Z Yeung; Michael G Wientjes; Ze Lu; M Guillaume Wientjes
Journal:  Adv Drug Deliv Rev       Date:  2015-12-11       Impact factor: 15.470

3.  Enhancement of fluid filtration across tumor vessels: implication for delivery of macromolecules.

Authors:  P A Netti; L M Hamberg; J W Babich; D Kierstead; W Graham; G J Hunter; G L Wolf; A Fischman; Y Boucher; R K Jain
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-16       Impact factor: 11.205

Review 4.  Drug delivery and transport to solid tumors.

Authors:  Seong Hoon Jang; M Guillaume Wientjes; Dan Lu; Jessie L S Au
Journal:  Pharm Res       Date:  2003-09       Impact factor: 4.200

5.  Angiotensin II (AII) induced hypertension chemotherapy (IHC) for unresectable gastric cancer: with reference to resection after down staging.

Authors:  H Sato; K Sugiyama; M Hoshi; M Urushiyama; K Ishizuka
Journal:  World J Surg       Date:  1995 Nov-Dec       Impact factor: 3.352

6.  Tumor-selective blood flow decrease induced by an angiotensin converting enzyme inhibitor, temocapril hydrochloride.

Authors:  K Hori; S Saito; H Takahashi; H Sato; H Maeda; Y Sato
Journal:  Jpn J Cancer Res       Date:  2000-02

7.  Enhanced tumor localization of monoclonal antibody by treatment with kininase II inhibitor and angiotensin II.

Authors:  A Noguchi; T Takahashi; T Yamaguchi; K Kitamura; A Noguchi; H Tsurumi; K Takashina; H Maeda
Journal:  Jpn J Cancer Res       Date:  1992-03

8.  Effects of intravenous infusion of dopamine on tumor blood flow in rat subcutis.

Authors:  S Tanda; K Hori; S Saito; Q H Zhang; H C Li; M Suzuki
Journal:  Jpn J Cancer Res       Date:  1994-05
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.